111 related articles for article (PubMed ID: 35779823)
1. Statins were not associated with hepatocellular carcinoma after controlling for time-varying confounders in patients with diabetes.
Yeh YC; Chen YY; Chen PC
J Clin Epidemiol; 2022 Oct; 150():98-105. PubMed ID: 35779823
[TBL] [Abstract][Full Text] [Related]
2. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
3. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
Tseng CH
Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
[TBL] [Abstract][Full Text] [Related]
4. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
[TBL] [Abstract][Full Text] [Related]
5. Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis.
Kim HW; Joo YS; Kang SC; Koh HB; Han SH; Yoo TH; Kang SW; Park JT
Sci Rep; 2022 Jun; 12(1):10807. PubMed ID: 35752695
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
[TBL] [Abstract][Full Text] [Related]
7. Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.
Yi SW; Kim SH; Han KJ; Yi JJ; Ohrr H
Br J Cancer; 2020 Mar; 122(5):630-633. PubMed ID: 31857717
[TBL] [Abstract][Full Text] [Related]
8. Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Goh MJ; Sinn DH; Kim S; Woo SY; Cho H; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Hepatology; 2020 Jun; 71(6):2023-2032. PubMed ID: 31556128
[TBL] [Abstract][Full Text] [Related]
9. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
Kim G; Jang SY; Nam CM; Kang ES
J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
[TBL] [Abstract][Full Text] [Related]
10. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
[TBL] [Abstract][Full Text] [Related]
11. Examining the association between statins and lung cancer incidence in patients with type 2 diabetes mellitus.
Dong YH; Lin JW; Wu LC; Chen CY; Chang CH; Chen KY; Lai MS
J Formos Med Assoc; 2014 Dec; 113(12):940-8. PubMed ID: 24051132
[TBL] [Abstract][Full Text] [Related]
12. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
Tsan YT; Lee CH; Wang JD; Chen PC
J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
[TBL] [Abstract][Full Text] [Related]
13. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study.
Na E; Cho S; Kim DJ; Choi J; Han E
Cardiovasc Diabetol; 2020 May; 19(1):67. PubMed ID: 32416728
[TBL] [Abstract][Full Text] [Related]
14. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
Lee TY; Wu JC; Yu SH; Lin JT; Wu MS; Wu CY
Int J Cancer; 2017 Oct; 141(7):1307-1314. PubMed ID: 28509327
[TBL] [Abstract][Full Text] [Related]
15. Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia.
Chen HH; Lin MC; Muo CH; Yeh SY; Sung FC; Kao CH
Medicine (Baltimore); 2015 Jun; 94(24):e1013. PubMed ID: 26091447
[TBL] [Abstract][Full Text] [Related]
16. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
Cho Y; Kim MS; Nam CM; Kang ES
Sci Rep; 2019 Feb; 9(1):1467. PubMed ID: 30728421
[TBL] [Abstract][Full Text] [Related]
17. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.
Thrift AP; Natarajan Y; Liu Y; El-Serag HB
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2117-2125.e3. PubMed ID: 30625400
[TBL] [Abstract][Full Text] [Related]
18. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis.
Wang J; Li X
Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1603-1609. PubMed ID: 33405428
[TBL] [Abstract][Full Text] [Related]
19. Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: A population-based cohort study.
Pan SW; Yen YF; Feng JY; Chuang PH; Su VY; Kou YR; Su WJ; Chan YJ
Br J Clin Pharmacol; 2020 Mar; 86(3):569-579. PubMed ID: 31633826
[TBL] [Abstract][Full Text] [Related]
20. Association of statins with diabetes mellitus and diabetic complications: role of confounders during follow-up.
Mansi IA; Frei CR; Halm EA; Mortensen EM
J Investig Med; 2017 Jan; 65(1):32-42. PubMed ID: 27574296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
